期刊文献+

C26腺癌恶病质动物模型的自然发展过程 被引量:5

Natural developing process of the cancer cachexia-inducing C26 colon carcinoma in mice
原文传递
导出
摘要 目的观察C26腺癌恶病质动物模型的自然发展过程。方法于BALB/C小鼠接种结肠腺癌Colon26(C26)细胞,在接种后0、5、10、15、20、25d,记录小鼠腓肠肌、附睾和去瘤体质量,检测生化指标、肿瘤坏死因子-α(TNF—α)和组织核因子-κB(NF—κB)及泛素蛋白酶体的E3连接酶(Atrogin)-l和肌肉环状指蛋白(MURF)-1基因的表达。结果本模型明显的营养不良和代谢紊乱发生在肿瘤接种后15d。荷瘤组F组较空白对照G组:白蛋白浓度分别为(14.44±1.12)、(19.80±2.45)g/L,(P〈0.01);其他生化指标:TNF-α和NF—κB及泛素蛋白酶体的激活也有不同程度改善(P〈0.05)。结论癌症恶病质从起始发展到出现明显症状是一个较长的过程;血清白蛋白可以作为判断肿瘤患者是否发生恶病质的指标之一。 Objective To observe the natural developing process of the cancer cachexia-inducing C26 colon carcinoma in mice. Methods The murine colon 26 adenocarcinoma cells was inoculated subcu- taneously into BALB/C mice. On the day 0, 5, 10, 15, 20, and 25 after inoculation, body weight and gastrocnemius muscle with epididymal adipose were documented. Biochemical parameters, serum tumor necrosis factor-α (TNF-α), the expression of nuclear factor-κB (NF-κB) in tumor and expression of ubiq- uitin proteasome E3 ligase ( Atrogin-1 ) and muscle ring finger protein 1 ( MURF-1 ) genese were valuated. Results Remarkable malnutrition and metabolic disorder occured about 15 days after the tumor inoculation in this model. There was significant difference in the concentrations of serum albumin between tumor-bear- ing group and healthy control group at the 15th day [ ( 14. 44 ± 1.12) vs ( 19. 80 ±2. 45) g/L,P 〈0. 01 ]. The other biochemical indicators, TNF-α, NF-κB, and Atrogin-1 and MuRF-1 had beneficial changes to varying degrees (P 〈 0. 05 ). Conclusion Cancer cachexia development from the inoculated tumour ceils to the obvious symptoms is a long process. The serum albumin may serve as an indicator to judge cancer cachexia development.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2012年第7期1331-1334,共4页 Chinese Journal of Experimental Surgery
基金 福建医科大学教授学术发展基金资助项目(Js06045)
关键词 结肠腺癌 恶病质 模型 动物 Colon carcinoma Cachexia Model, animal
  • 相关文献

参考文献6

二级参考文献9

  • 1郑启昌,张勇,秦涛,卢昕,熊俊.肿瘤坏死因子-α对肿瘤抑制基因RECK在HepG2细胞中表达的调节作用[J].中华实验外科杂志,2006,23(6):685-687. 被引量:3
  • 2Bossola M,Pacelli F,Tortorelli A,et al.Cancer cachexia:it' s time for more clinical trials.Ann Surg Oncol,2007,14:276-285. 被引量:1
  • 3Soslow RA,Dannenberg AJ,Rush D,et al.Cox-2 is expressed in human pulmonary,colonic,and mammary tumors.Cancer,2000,89:2637-2645. 被引量:1
  • 4Strassmann G,Fong M,Kenney JS,et al.Evidence for the involvement of interleukin 6 in experimental cancer cachexia.Chn Invest,1992,89:1681-1684. 被引量:1
  • 5Darling G,Fraker DL,Jensen JC,et al.Cachectic effects of recombinant human tumor necrosis factor in rats.Cancer Res,1990,50:4008-4013. 被引量:1
  • 6Ye RD,Li C,Kao R,et al.Regulation of nuclear factor Kappa B activation by G-protein-coupled receptors.Leukoc Biol,2001,70:839-848. 被引量:1
  • 7Baeuerle PA,Baltimore D.NF-κB:ten years after.Cell,1996,87; 13-20. 被引量:1
  • 8R. J. Schaur,H. Fellier,H. Gleispach,E. Fink,L. Kronberger. Tumor host relations[J] 1979,Journal of Cancer Research and Clinical Oncology(3):281~285 被引量:1
  • 9周伟,江志伟,姜军,黎介寿.一种癌性恶病质动物模型的建立[J].中华实验外科杂志,2004,21(4):490-491. 被引量:22

共引文献27

同被引文献59

  • 1赵艳凤,姜达.癌性恶病质发生的分子机制及其逆转[J].实用肿瘤学杂志,2007,21(2):169-172. 被引量:13
  • 2Fearon K,Strasser F, Anker SD, et al. Definition and classification of cancer cachexia : an international consensus. Lancet Oncol, 2011,12 : 489-495. 被引量:1
  • 3Murphy KT, Lynch GS. Update on emerging drugs for cancer cachexi- a. Expert Opin Emerg Drugs,2009,14:619-632. 被引量:1
  • 4Ju J, Lu G, Lambert JI3, et al. Inhibition of carcinogenesis by tea con- stituents. Semin Cancer Biol,2007,17:395-402. 被引量:1
  • 5Wang H, Lai YJ, Chan YL, et al. Epigallocatechin-3-gallate effectively attenuates skeletal muscle atrophy caused by cancer cachexia. Cancer Lett ,2011,305:40-49. 被引量:1
  • 6Pinheiro CH, Gerlinger - Romero F, Goimares - Ferreira L, et al. Metabolic and functional effects of beta-hydroxy-beta-methyl butyrate (HMB) supplementation in skeletal muscle. Eur J Appl Physio1,2012, 112:2531-2537. 被引量:1
  • 7Nunes EA, Kuczera D, Brito GA, et al. ]-Hydroxy-l-methylbutyrate supplementation reduces tumor growth and tumor cell proliferation ex vivo and prevents cachexia in Walker 256 tumor-bearing rats by modif- ying nuclear factor-KB expression. Nutr Res,2008,28:487-493. 被引量:1
  • 8Dianliang Z.Probing cancer cachexia-anorexia:recent results with knock-out,transgene andpolyraorphisms.Curr Opin Clin Nutr Metab Care,2009,12:227-231. 被引量:1
  • 9Goll DE,Neti G,Mares SW,et al.Myofibrillar protein turnover:Theproteasome and the calpains.J Anim Sci,2008,86:E19-E35. 被引量:1
  • 10Aulino P,Berardi E,Cardillo VM,et al.Molecular,cellular and physi-ological characterization of the cancer cachexia-inducing C26 coloncarcinoma in mouse.BMC Cancer,2010,10:363. 被引量:1

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部